Who Paid My Doc
P2 Moderate-Severe pDLE
Research payments
$205,685
Through program year 2025, $205,685 in research payments was reported against P2 Moderate-Severe pDLE, across 52 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $110,873 | 21 |
| 2024 | Research | $94,812 | 31 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jeffrey Weinberg New York, NY Named on 5 payments
- Scott Fretzin Indianapolis, IN Named on 4 payments
- Victoria Werth Philadelphia, PA Named on 3 payments
- Wendy Sadoff Farmington Hills, MI Named on 3 payments
- Abraham Korman Gahanna, OH Named on 2 payments
- Paul Wallace Los Angeles, CA Named on 2 payments
- Sunil Dhawan Fremont, CA Named on 2 payments
- Lauren Campbell Cypress, TX Named on 2 payments
- Melody Stone Saint Joseph, MO Named on 2 payments
- Edward Primka Knoxville, TN Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.